摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(1'-deoxy-2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)prop-1-ene | 53263-18-6

中文名称
——
中文别名
——
英文名称
3-(1'-deoxy-2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)prop-1-ene
英文别名
3-(2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)-1-propene;1-deoxy-1-allyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside;3-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-propene;1-allyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside;3-(2,3,4,6-tetra-O-acetyl-b-d-galactopyranosyl)-1-propene;allyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside;[(2R,3S,4R,5S,6S)-3,4,5-triacetyloxy-6-prop-2-enyloxan-2-yl]methyl acetate
3-(1'-deoxy-2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)prop-1-ene化学式
CAS
53263-18-6;82659-53-8;98920-44-6;98920-46-8;98920-49-1;103773-87-1;98920-48-0
化学式
C17H24O9
mdl
——
分子量
372.372
InChiKey
LJLBJVZTDBJHTM-BQJWPVKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    75-76 °C
  • 沸点:
    416.8±38.0 °C(Predicted)
  • 密度:
    1.21±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    26
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    114
  • 氢给体数:
    0
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design and synthesis of C-linked fucosides as inhibitors of E-selectin
    摘要:
    Two series of C-linked fucosides as mimetics for the tetrasaccharide sialyl Lewis X have been synthesized and tested as inhibitors of E-Selectin. The fucopeptides have been prepared from three key intermediates, including alpha-C-allyl fucose, natural and unnatural amino acids bearing hydroxyl groups and an alpha,omega-diacid moiety for the imitation of the essential three parts of SLe(x), i.e., the Fuc, Gal, and NeuAc. The nature and distance of the linkage of the fucose moiety to the amino acids as well as the distance between the amino acids and the terminal carboxylic acid group turned out to be crucial for the biological activity. In addition the necessity of both OH groups (4- and 6-OH) in the Gal part could be confirmed. Conformational NMR study of the most active mimetic supports the structure-activity relationship. A second series of mimetics was prepared, where Fuc and Gal moieties were purely C-linked. In the synthesis of beta-C-allyl galactose an intramolecular 1,2-hydride shift led to an interesting side product. However, the substituted glycosidic oxygens led to a substantial loss of conformational constrain, which could not be compensated and resulted in low activity. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0968-0896(96)00127-7
  • 作为产物:
    描述:
    2,3,4,6-tetra-O-acetyl-1-bromo-β-D-galactopyranosyl chloride 在 偶氮二异丁腈三正丁基氢锡 作用下, 以 为溶剂, 反应 0.83h, 生成 3-(1'-deoxy-2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)prop-1-ene
    参考文献:
    名称:
    立体控制获取高糖(非 1-en-4-ulopyranosyl 衍生物)和糖模拟物 [3-(β-D-Glycopyranosyl)-1-propenes and (3Z)-4,8-​​Anhydro-nona-1,3-二烯醇]
    摘要:
    全乙酰化 1-溴-β-D-吡喃葡萄糖基氯与烯丙基三丁基锡在光解条件下反应,得到相应的乙酰化 α-D-non-1-en-4-ulopyranosyl 氯。产量不同,主要取决于母糖的配置(D-葡萄糖:86%;D-半乳糖:51%;D-甘露糖:31%)。水解产生的相应乙酰化 α-D-non-1-en-4-ulopyranoses 作为副产物获得(8-23% 产率)。由 nBu3SnH 介导的乙酰化 α-D-non-1-en-4-ulopyranosyl 氯化物的自由基还原导致 glycopyranos-1-yl 自由基,其非对映选择性猝灭产生乙酰化 3-(β-D-glycopyranosyl)- 1-丙烯具有良好的总产率(50-57% 产率)。这种方法结合了涉及吡喃糖基自由基的 C-C 和 C-H 键形成反应,构成了乙酰化 3-(β-D-吡喃葡萄糖基)-1-丙烯的更有效途径。没有检测到 3-(α-
    DOI:
    10.1002/1099-0690(200008)2000:16<2831::aid-ejoc2831>3.0.co;2-0
点击查看最新优质反应信息

文献信息

  • Synthesis of <i>C</i> ‐Glycosyl Amino Acid Building Blocks Suitable for the Solid‐Phase Synthesis of Multivalent Glycopeptide Mimics
    作者:Niels R. M. Reintjens、Tony S. Koemans、Nick Zilverschoon、Riccardo Castelli、Robert A. Cordfunke、Jan Wouter Drijfhout、Nico J. Meeuwenoord、Herman S. Overkleeft、Dmitri V. Filippov、Gijsbert A. Marel、Jeroen D. C. Codée
    DOI:10.1002/ejoc.202000587
    日期:2020.8.31
    C-glycosyl functionalized lysine building blocks, featuring C-glycosidic derivatives of alpha-rhamnose, alpha-mannose, alpha-galactose, beta-galactose, and beta-N-acetyl glucosamine have been designed and synthesized. These derivatives, equipped with acid-labile protecting groups, are eminently suitable for solid-phase synthesis of multivalent glycopeptides. The lysine building blocks were prepared fromC-allyl
    已经设计并合成了五个 C-糖基功能化赖酸构件,其特征是 α-鼠李糖、α-甘露糖、α-半乳糖、β-半乳糖和β-N-乙酰氨基葡萄糖的 C-糖苷衍生物。这些衍生物带有酸不稳定保护基团,非常适合多价糖肽的固相合成。赖酸结构单元由 C-烯丙基糖苷制备,该糖苷经历了与丙烯酸酯的 Grubbs 交叉复分解,然后还原所得 α,β-不饱和酯中的 C=C 双键,并释放羧酸酯以允许缩合带有赖酸侧链。将由此得到的C-糖苷共五种,用于三种糖肽的固相肽合成(SPPS),
  • Combining Glycomimetic and Multivalent Strategies toward Designing Potent Bacterial Lectin Inhibitors
    作者:Yoann M. Chabre、Denis Giguère、Bertrand Blanchard、Jacques Rodrigue、Sylvain Rocheleau、Mathieu Neault、Subhash Rauthu、Alex Papadopoulos、Alexandre A. Arnold、Anne Imberty、René Roy
    DOI:10.1002/chem.201003402
    日期:2011.5.27
    As part of ongoing activities toward the design of potent and selective ligands against galactoside‐binding proteins from animal, bacterial, and plant lectins, a systematic investigation involving the synthesis and binding evaluations of a series of original β‐C‐galactopyranoside mimetics is described. The multivalent presentation of partly optimized candidates on various dendritic scaffolds through
    作为针对来自动物,细菌和植物凝集素的半乳糖苷结合蛋白的有效和选择性配体设计工作的一部分,对系统的研究进行了描述,该研究涉及一系列原始β- C-喃半乳糖苷模拟物的合成和结合评估。通过Cu I催化的叠氮化物-炔烃环加成反应(CuAAc),还实现了在各种树突状支架上部分优化的候选物的多价呈现。基于等温滴定量热法(ITC)的生物物理研究已经表明在低微摩尔范围内的解离常数为最佳优化单价缀合物(ķ d = 37μ中号)。因此,结果证实了稳定的C-半乳糖苷可能代表了致病性绿假单胞菌PA-IL凝集素(Lec A)的天然α-连接寡糖抑制剂的有效合成糖模拟物。对于三价,六价和九价衍生物,还观察到糖缀合物亲和力的惊人增强,其中最有力的解离常数低于500 n M,与β- D相比,亲和力增加了400倍。-Gal- Ø‐我用作参考。为了加深我们对识别过程中涉及的最佳糖模拟物结合模式的理解,已进行了分子建模研究,对
  • Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3
    作者:Denis Giguère、Ramesh Patnam、Marc-André Bellefleur、Christian St-Pierre、Sachiko Sato、René Roy
    DOI:10.1039/b517529a
    日期:——
    Galactosides and lactosides bearing triazoles or isoxazoles, regiospecifically prepared by [1,3]-dipolar cycloadditions between alkynes, azides or nitrile oxides, provided specific galectin-1 and -3 inhibitors with potencies as low as 20 µM.
    通过炔类、叠氮化物或腈类氧化物之间的[1,3]-二极环加成反应,对含有三唑或异噁唑的半乳糖苷和乳糖苷进行了区域特异性制备,提供了特异性的 galectin-1 和-3 抑制剂,其效力低至 20 µM。
  • Thiol–ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors
    作者:Mohamed-Chiheb Saada、Joanna Ombouma、Jean-Louis Montero、Claudiu T. Supuran、Jean-Yves Winum
    DOI:10.1039/c3cc42541j
    日期:——
    Thiol-ene click chemistry has been applied for obtaining sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitors incorporating sugar moieties. Most of these new compounds were moderate CA I inhibitors, effective CA II inhibitors, and low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms CA IX and XII.
    醇-点击化学已用于获得掺入糖部分的磺酰胺碳酸酐酶(CA,EC 4.2.1.1)抑制剂。这些新化合物中的大多数是中度CA I抑制剂,有效的CA II抑制剂以及与肿瘤相关的同工型CA IX和XII的低纳摩尔/亚纳摩尔分子抑制剂
  • 3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-Sites for High-Affinity and High-Selectivity Inhibition of Galectin-3
    作者:Alexander Dahlqvist、Santanu Mandal、Kristoffer Peterson、Maria Håkansson、Derek T. Logan、Fredrik R. Zetterberg、Hakon Leffler、Ulf J. Nilsson
    DOI:10.3390/molecules24244554
    日期:——
    The galectins are a family of galactose-binding proteins playing key roles in inflammatory processes and cancer. However, they are structurally very closely related, and discovery of highly selective inhibitors is challenging. In this work, we report the design of novel inhibitors binding to a subsite unique to galectin-3, which confers both high selectivity and affinity towards galectin-3. Olefin
    乳糖凝集素是一个半乳糖结合蛋白家族,在炎症过程和癌症中起关键作用。然而,它们在结构上非常密切相关,高选择性抑制剂的发现具有挑战性。在这项工作中,我们报告了与 galectin-3 特有的亚位点结合的新型抑制剂的设计,该亚位点对 galectin-3 具有高选择性和亲和力。烯丙基 β-C-喃半乳糖1-乙烯之间的烯烃交叉复分解或基甲基 β-C-喃半乳糖1-萘甲酸生物的酰化产生带有 1-酰胺结构元素的 C-喃半乳糖,该结构元素与亚半乳糖凝集素-3 独特位点相互作用对两种抑制剂-galectin-3 复合物的分子建模和 X 射线结构分析。亲和力降至亚 µM,选择性高于半乳糖凝集素-1、2、4个N端域、4个C端域、7、8个N端域、9个N端域和9个C端域均较高。这些结果表明,通过靶向独特的亚位点可以实现对单一半乳糖凝集素的高亲和力和选择性,这为进一步开发小而选择性的半乳糖凝集素抑制剂提供了希望。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸